WallStSmart

Grande Group Limited Class A Ordinary Shares (GRAN)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 75197216% more annual revenue ($2.17T vs $2.88M). NMR leads profitability with a 16.7% profit margin vs -9.8%. NMR earns a higher WallStSmart Score of 70/100 (B-).

GRAN

Avoid

14

out of 100

Grade: F

Growth: 3.3Profit: 2.5Value: 5.0Quality: 9.0
Piotroski: 4/9Altman Z: 3.63

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GRAN3 strengths · Avg: 9.3/10
Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.6310/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

NMR4 strengths · Avg: 9.0/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

Areas to Watch

GRAN4 concerns · Avg: 2.3/10
Market CapQuality
$25.40M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-5.8%2/10

ROE of -5.8% — below average capital efficiency

Revenue GrowthGrowth
-83.2%2/10

Revenue declined 83.2%

EPS GrowthGrowth
-70.6%2/10

Earnings declined 70.6%

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : GRAN

The strongest argument for GRAN centers on Debt/Equity, Altman Z-Score, Price/Book.

Bull Case : NMR

The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bear Case : GRAN

The primary concerns for GRAN are Market Cap, Return on Equity, Revenue Growth.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Key Dynamics to Monitor

GRAN profiles as a turnaround stock while NMR is a growth play — different risk/reward profiles.

NMR is growing revenue faster at 27.5% — sustainability is the question.

GRAN generates stronger free cash flow (33,840), providing more financial flexibility.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (70/100 vs 14/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Grande Group Limited Class A Ordinary Shares

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Grande Group Limited, provides corporate finance advisory services in Hong Kong, the People's Republic of China, and Singapore.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?